Tablets
- Conventional/Immediate Release
- Modified Release
- Effervescent Tablets
- Chewable Tablets
Capsules
- Soft Gelatin Capsules/Soft gels
- Hard Gelatin Capsules
Powders & Granules Lozenges & Pastilles Gummies
Contract Manufacturing of Oral Solids Market size was valued at USD x billion in 2022 and is expected to reach USD x billion by 2029, at a CAGR of x% during the forecast period 2023 to 2029 owing to increase in outsourcing by the innovator companies on branded products results in approximately 40% to 60 % cost savings to the company and are expected to drive the growth of the market. Moreover, increasing number of contract manufacturing organizations coupled advanced manufacturing technologies fuels the growth of the market. However, high supplier switching cost and risks related to data confidentiality and exclusivity are expected to hamper the growth of the market. The report studies global contract manufacturing of oral solids market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. global contract manufacturing of oral solids market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
In contract manufacturing of oral solids, information such as product formula has to be transferred from client (innovator) companies to suppliers (CMOs) which involves the risk i.e. related to data confidentiality and exclusivity. The service provider after the completion of agreement might become the competitor for innovator for the particular product. Moreover, the buyers have to pay high switching cost to the service providers due to need for compatibility with the manufacturing equipment required that is expected to limit the growth of the contract manufacturing of oral solids market.
Tablets
Capsules
Powders & Granules Lozenges & Pastilles Gummies
The key segments covered in the Contract Manufacturing of Oral Solids Market are: by product type and by end user
The Contract Manufacturing of Oral Solids Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
North America is the fastest-growing for Contract Manufacturing of Oral Solids Market
1. Executive Summary
2. Global Contract Manufacturing of Oral solids Market Introduction
2.1. Global Contract Manufacturing of Oral solids Market Taxonomy
2.2. Global Contract Manufacturing of Oral solids Market Definitions
2.2.1. By Product Type
2.2.2. By End User
3. Global Contract Manufacturing of Oral solids Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Contract Manufacturing of Oral solids Market Dynamics Factors Impact Analysis
4. Global Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Contract Manufacturing of Oral solids Market Forecast, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029
5.1. Tablets
5.1.1. Conventional/Immediate Release
5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Modified Release
5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Effervescent Tablets
5.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Chewable Tablets
5.1.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Capsules
5.2.1. Soft Gelatin Capsules/Soft gels
5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Hard Gelatin Capsules
5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.3. Powders & Granules
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Lozenges & Pastilles
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Gummies
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Contract Manufacturing of Oral solids Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
6.1. Big Pharma or Biotechnology Companies
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Small & Medium Size Pharma/Biotech Companies
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Emerging/virtual Pharma Companies
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Nutraceutical Companies
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Contract Manufacturing of Oral solids Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. The Middle East & Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Region, 2023 - 2029
8. North America Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
8.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Tablets
8.1.1.1. Conventional/Immediate Release
8.1.1.2. Modified Release
8.1.1.3. Effervescent Tablets
8.1.1.4. Chewable Tablets
8.1.2. Capsules
8.1.2.1. Soft Gelatin Capsules/Soft gels
8.1.2.2. Hard Gelatin Capsules
8.1.3. Powders & Granules
8.1.4. Lozenges & Pastilles
8.1.5. Gummies
8.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Big Pharma or Biotechnology Companies
8.2.2. Small & Medium Size Pharma/Biotech Companies
8.2.3. Emerging/virtual Pharma Companies
8.2.4. Nutraceutical Companies
8.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029
8.5. North America Contract Manufacturing of Oral solids Market Dynamics Trends
9. Europe Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
9.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tablets
9.1.1.1. Conventional/Immediate Release
9.1.1.2. Modified Release
9.1.1.3. Effervescent Tablets
9.1.1.4. Chewable Tablets
9.1.2. Capsules
9.1.2.1. Soft Gelatin Capsules/Soft gels
9.1.2.2. Hard Gelatin Capsules
9.1.3. Powders & Granules
9.1.4. Lozenges & Pastilles
9.1.5. Gummies
9.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Big Pharma or Biotechnology Companies
9.2.2. Small & Medium Size Pharma/Biotech Companies
9.2.3. Emerging/virtual Pharma Companies
9.2.4. Nutraceutical Companies
9.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029
9.5. Europe Contract Manufacturing of Oral solids Market Dynamics Trends
10. Asia Pacific Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
10.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tablets
10.1.1.1. Conventional/Immediate Release
10.1.1.2. Modified Release
10.1.1.3. Effervescent Tablets
10.1.1.4. Chewable Tablets
10.1.2. Capsules
10.1.2.1. Soft Gelatin Capsules/Soft gels
10.1.2.2. Hard Gelatin Capsules
10.1.3. Powders & Granules
10.1.4. Lozenges & Pastilles
10.1.5. Gummies
10.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Big Pharma or Biotechnology Companies
10.2.2. Small & Medium Size Pharma/Biotech Companies
10.2.3. Emerging/virtual Pharma Companies
10.2.4. Nutraceutical Companies
10.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. ASEAN Counties
10.3.5. Philippines
10.3.6. Rest of Asia Pacific
10.4. Asia Pacific Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029
10.5. Asia Pacific Contract Manufacturing of Oral solids Market Dynamics Trends
11. Latin America Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
11.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tablets
11.1.1.1. Conventional/Immediate Release
11.1.1.2. Modified Release
11.1.1.3. Effervescent Tablets
11.1.1.4. Chewable Tablets
11.1.2. Capsules
11.1.2.1. Soft Gelatin Capsules/Soft gels
11.1.2.2. Hard Gelatin Capsules
11.1.3. Powders & Granules
11.1.4. Lozenges & Pastilles
11.1.5. Gummies
11.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Big Pharma or Biotechnology Companies
11.2.2. Small & Medium Size Pharma/Biotech Companies
11.2.3. Emerging/virtual Pharma Companies
11.2.4. Nutraceutical Companies
11.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Mexico
11.3.2. Brazil
11.3.3. Argentina
11.3.4. Chile
11.3.5. Rest of Latin America
11.4. Latin America Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029
11.5. Latin America Contract Manufacturing of Oral solids Market Dynamics Trends
12. Middle East and Africa Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
12.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Tablets
12.1.1.1. Conventional/Immediate Release
12.1.1.2. Modified Release
12.1.1.3. Effervescent Tablets
12.1.1.4. Chewable Tablets
12.1.2. Capsules
12.1.2.1. Soft Gelatin Capsules/Soft gels
12.1.2.2. Hard Gelatin Capsules
12.1.3. Powders & Granules
12.1.4. Lozenges & Pastilles
12.1.5. Gummies
12.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Big Pharma or Biotechnology Companies
12.2.2. Small & Medium Size Pharma/Biotech Companies
12.2.3. Emerging/virtual Pharma Companies
12.2.4. Nutraceutical Companies
12.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Saudi Arabia
12.3.4. Turkey
12.3.5. Rest of MEA
12.4. Middle East and Africa Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029
12.5. Middle East and Africa Contract Manufacturing of Oral solids Market Dynamics Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Recipharm AB
13.2.2. AbbVie Contract Manufacturing
13.2.3. Patheon N.V.
13.2.4. Catalent Inc.
13.2.5. NextPharma
13.2.6. Capsugel (Lonza Group AG)
13.2.7. Aurobindo Pharma Limited (AuroSource)
13.2.8. Siegfried AG
13.2.9. Piramal Pharma Solutions
13.2.10. CordenPharma
14. Research Methodology
15. Key Assumptions and Acronyms